|
[1]
|
张思维, 郑荣寿, 李霓等.中国肝癌发病的趋势分析和预测[J].中华预防医学杂志, 2012, 46(7): 587-592.
|
|
[2]
|
吴孟超, 周伟平, 潘泽西. 肝癌外科治疗新挑战[J]. 传染病信息, 2012, 25(5): 257-259,263.
|
|
[3]
|
汤钊献. 21世纪肝癌临床研究面临的挑战[J]. 临床肝胆病杂志, 2012, 28(4): 241-241.
|
|
[4]
|
樊嘉, 潘奇, 史颖弘. 美国、亚太和中国肝癌共识比较[J]. 临床肝胆病杂志, 2011, 27(4): 346-348.
|
|
[5]
|
中华人民共和国卫生部(卫办医政发[2011] 121号). 原发性肝癌诊疗规范(2011年版)[J]. 临床肿瘤学杂志, 2011, 16(10): 929-946.
|
|
[6]
|
郑作深, 邹雨荷, 饶健等. 460例巨大肝癌放射治疗的技术改进[J]. 临床肿瘤学杂志, 2005, 10(5): 497-501.
|
|
[7]
|
郑作深. 从临床实践看移动条野放射治疗肝癌的价值[J]. 胃肠病学和肝病学杂志, 2009, 18(7): 672-677.
|
|
[8]
|
郑作深, 叶林, 李卓永. 肝癌转移复发的研究进展[J]. 现代生物医学进展, 2009, 9(21): 4184-4186,4082.
|
|
[9]
|
W. P. Zhou, E. C. Lai, A. J. Li, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Annals of Surgery, 2009, 249(2): 195-202.
|
|
[10]
|
I. S. Kim, Y. S. Lim, H. C. Lee, et al. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Alimentary Phar- macology & Therapeutics, 2008, 27(4): 338-345.
|
|
[11]
|
Z. Wang, Z. Li, Y. Ji. Postoperative TACE should be recommended in the HCC treatment guidelines of the American association for the study of liver diseases. Hepatology, 2011, 54(4): 1489-1490.
|
|
[12]
|
秦叔逵. 治疗肝细胞癌别只盯着靶向药[N]. 健康报网医学论坛, 2013-02-04.
|
|
[13]
|
J. V. Simone. 医学界三大真相[J]. 肿瘤时讯肿瘤时讯, 2013, 10(14): 9.
|
|
[14]
|
M. Shi, C. Q. Zhang, Y. Q. Zhang, et a1. Micrometastases of solitary hepatoeellular carcinoma and appropriate resection mar- gin.World Journal of Surgery, 2004, 28: 376-381.
|
|
[15]
|
张同琳, 马少华, 修典荣等.原发性肝癌全肝切除标本的病理解剖学特征及其启示[J]. 中华外科杂志, 2010, 48(13): 964- 967.
|
|
[16]
|
石明, 张昌卿, 冯凯涛等.肝细胞癌周围微转移分布的研究[J].中华肿瘤杂志, 2002, 24(3): 257-260.
|
|
[17]
|
徐彬, 李强, 付丽等. 肝细胞癌肝内微转移的研究[J]. 中华普通外科杂志, 2006, 21(8): 577-579.
|
|
[18]
|
丛文铭, 董辉, 王斌等. 复发性肝癌临床病理特点与发生方式探讨[J]. 中国实用外科杂志, 2009, 29(1): 71-73.
|
|
[19]
|
H. Nishikawa, T. Inuzuka, H. Takeda, et al. A Case of advanced hepatocellular carcinoma with portal vein tumor thrombus re- fractory to epirubicin that showed marked decrease in tumor markers after transcatheter arterial infusion with miriplatin. Case Reports in Oncology, 2011, 4(2): 327-335.
|
|
[20]
|
X. Y. Lu, T. Xi, W. Y. Lou, et al. Palhobiological features of small hapatocallalar cacinoma: Correlation between tumor size and biological behavior. Journal of Cancer Research and Clinical Oncology, 2010, 137(4): 567-575.
|
|
[21]
|
M. Kojiro. Pathology. In: T. Livraghi, M. Makuuchi, L. Buscarini, Eds., Diagnosis and treatment of hepatocellular carcinoma. London: Greenwich Medical Media, 1997: 35.
|
|
[22]
|
K. Uka, T. Aikata, M. Karikomi, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepato- cellular carcinoma. World Journal of Gastroenterology, 2007, 19(3): 414-420.
|
|
[23]
|
H. Toyoda, Y. Fukuda, Y. Koyama, Y. Koyama, et al. Case report: Multiple systemic lymph node metastases from a small hepatocellular carcinoma. Journal of Gastroenterology and Hepatology, 1996, 11(10): 959-962.
|
|
[24]
|
李天然, 田嘉和. 肝癌PET/CT研究进展[J]. 军医进修学院, 2009, 30(2): 230-231.
|
|
[25]
|
扬国仁, 王晓慧. 正电子药物显像在肝癌在诊疗中的应用进展[J]. 中国医疗器械信息, 2009, 15: 4-8..
|
|
[26]
|
ICRU. Prescribing, recording and reporting photon beam therapy. ICRU Report 50, 1993.
|
|
[27]
|
ICRU. Prescribing, recording and reporting photon beam therapy. ICRU Report 62, 1996.
|
|
[28]
|
王鑫, 何少琴. 精确放疗所面对的生物学问题[J]. 中华肿瘤防治杂志, 2006, 13(10): 1-4.
|
|
[29]
|
夏云飞, 钱剑扬, 郑作深. 移动条野技术的放射生物学和剂量学基础及改进[J]. 癌症, 2000, 19(1): 82-85.
|
|
[30]
|
黄贤湛. 移动条野中平面剂量分析[J]. 基层医学论坛, 2006, 10(2): 116-117.
|
|
[31]
|
吴孟超, 李爱军. 应重视大肝癌的综合治疗[J]. 中华医学杂志, 2006, 86(24):1657-1689.
|
|
[32]
|
黄尚校, 刘敏, 梁世雄等. 283例原发性肝癌三维适形放疗的预后因素分析[J]. 中国癌症防治杂志, 2012, 4(2): 163-166.
|
|
[33]
|
F. Mornex, N. Girard, C. Beziat, et al. Feasibility and efficacy of high dose three dimensional radiotherapy in cirrhotic patients with small size hepatocellular carcinomanon-eligible for curative therapies mature results of the French phase Ⅱ RTF 1 trial. International Journal of Radiation Oncology, Biology, Physics, 2006, 66(4): 1152-1158.
|
|
[34]
|
M. T. Liu, S. H. Li, T. C. Chu, et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited fortranscatheter arterial chemoembolization. Japanese Journal of Clinical Oncology, 2004, 34(9): 532-539.
|
|
[35]
|
T. H. Kim, D. Y. Kim, J. W. Park, et al. Three dimensional con formal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoem bolization was ineffective or unsuitable. American Journal of Clinical Oncology, 2006, 29(6): 568-575.
|
|
[36]
|
蒋国梁. 原发性肝癌三维适形和调强放疗的基础和临床研究[J]. 中国工程科学, 2009,11(10): 129-136.
|
|
[37]
|
居小萍, 张晓青, 肖作平等. 三维适形放射治疗原发性肝癌65例疗效分析[J]. 中国肿瘤, 2007,16: 735-737.
|
|
[38]
|
陈光烈. 肝动脉灌注化疗结合三维适形放疗的疗效[J]. 当代医学, 2010, 18(3): 38-39.
|
|
[39]
|
任宝志, 钟立松, 袁建军等. 18FDG PET/CT定位三维适形放疗结合介入治疗原发性肝癌的疗效和预后分析[J]. 现代肿瘤医学, 2011,19(3): 504-507.
|
|
[40]
|
于金明, 袁双虎. 肿瘤放疗的发展与挑战[J]. 山东大学学报(医学版), 2011, 49(10): 48-56,66.
|
|
[41]
|
J. Choudhury, A. J. Sanyai. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clinical Liver Disease, 2004, 8(3): 575-594.
|